Welcome Guest | Register / Login

Asia Pacific Anticoagulants Market Forecast 2021-2028

Table of Contents

1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. SURGING PREVALENCE OF CHRONIC DISEASE
3.1.2. ADVANCEMENTS IN TECHNOLOGY
3.1.3. RISING APPROVAL OF NOVEL ORAL ANTICOAGULANTS (NOACS)
3.2. KEY RESTRAINTS
3.2.1. SIDE EFFECTS ASSOCIATED WITH ANTICOAGULANTS TREATMENT
3.2.2. HIGH PRICE OF NOACS
4. KEY ANALYTICS
4.1. PORTER'S FIVE FORCES ANALYSIS
4.1.1. THREAT OF NEW ENTRY
4.1.2. THREAT OF SUBSTITUTION
4.1.3. BUYER'S POWER
4.1.4. SUPPLIER'S POWER
4.1.5. COMPETITIVE RIVALRY
4.2. IMPACT OF COVID-19 ON ANTICOAGULANTS MARKET
4.3. OPPORTUNITY MATRIX
4.4. VENDOR LANDSCAPE
4.5. KEY INVESTMENT INSIGHTS
5. MARKET BY APPLICATION
5.1. ATRIAL FIBRILLATION & HEART ATTACK
5.2. PULMONARY EMBOLISM (PE)
5.3. DEEP VEIN THROMBOSIS (DVT)
5.4. STROKE
5.5. OTHER APPLICATIONS
6. MARKET BY ROUTE OF ADMINISTRATION
6.1. ORAL ANTICOAGULANTS
6.2. INJECTABLE ANTICOAGULANTS
7. MARKET BY DRUG CLASS
7.1. NOACS
7.2. HEPARINS & LOW-MOLECULAR-WEIGHT HEPARINS (LMWHS)
7.3. VITAMIN K ANTAGONISTS
7.4. OTHER DRUG CLASS
8. GEOGRAPHICAL ANALYSIS
8.1. ASIA PACIFIC
8.1.1. MARKET SIZE & ESTIMATES
8.1.2. KEY GROWTH ENABLERS
8.1.3. KEY CHALLENGES
8.1.4. KEY PLAYERS
8.1.5. COUNTRY ANALYSIS
8.1.5.1. CHINA
8.1.5.2. JAPAN
8.1.5.3. AUSTRALIA & NEW ZEALAND
8.1.5.4. INDIA
8.1.5.5. SOUTH KOREA
8.1.5.6. THAILAND
8.1.5.7. INDONESIA
8.1.5.8. VIETNAM
8.1.5.9. REST OF ASIA PACIFIC
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. MERGER & ACQUISITIONS
9.1.2. PRODUCT LAUNCH & DEVELOPMENTS
9.1.3. PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
9.1.4. BUSINESS EXPANSION/ APPROVAL/ ANNOUNCEMENT
9.2. COMPANY PROFILE
9.2.1. ABBOTT LABORATORIES
9.2.2. ALEXION PHARMACEUTICAL INC
9.2.3. ASPEN PHARMACARE HOLDINGS LIMITED
9.2.4. BAYER AG
9.2.5. BOEHRINGER INGELHEIM GMBH
9.2.6. BRISTOL-MYERS SQUIBB COMPANY
9.2.7. DAIICHI SANKYO
9.2.8. DR. REDDY'S LABORATORIES
9.2.9. GLAXOSMITHKLINE PLC
9.2.10. JOHNSON & JOHNSON
9.2.11. LEO PHARMA AS
9.2.12. MERCK & CO
9.2.13. NOVARTIS AG
9.2.14. PFIZER INC
9.2.15. SANOFI

List Of Tables

TABLE 1: MARKET SNAPSHOT - ANTICOAGULANTS
TABLE 2: ASIA PACIFIC ANTICOAGULANTS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: ASIA PACIFIC ANTICOAGULANTS MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: ASIA PACIFIC ANTICOAGULANTS MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: ASIA PACIFIC ANTICOAGULANTS MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: ASIA PACIFIC ANTICOAGULANTS MARKET, BY DRUG CLASS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: ASIA PACIFIC ANTICOAGULANTS MARKET, BY DRUG CLASS, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: ASIA PACIFIC ANTICOAGULANTS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: ASIA PACIFIC ANTICOAGULANTS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE10: LEADING PLAYERS OPERATING IN ASIA PACIFIC ANTICOAGULANTS MARKET

List Of Figures

FIGURE 1: PORTER'S FIVE FORCE ANALYSIS
FIGURE 2: OPPORTUNITY MATRIX
FIGURE 3: VENDOR LANDSCAPE
FIGURE 4: KEY INVESTMENT INSIGHTS
FIGURE 5: ASIA PACIFIC ANTICOAGULANTS MARKET, BY APPLICATION, IN 2020
FIGURE 6: ASIA PACIFIC ANTICOAGULANTS MARKET, BY ATRIAL FIBRILLATION & HEART ATTACK, 2021-2028 (IN $ MILLION)
FIGURE 7: ASIA PACIFIC ANTICOAGULANTS MARKET, BY PULMONARY EMBOLISM (PE), 2021-2028 (IN $ MILLION)
FIGURE 8: ASIA PACIFIC ANTICOAGULANTS MARKET, BY DEEP VEIN THROMBOSIS (DVT), 2021-2028 (IN $ MILLION)
FIGURE 9: ASIA PACIFIC ANTICOAGULANTS MARKET, BY STROKE, 2021-2028 (IN $ MILLION)
FIGURE 10: ASIA PACIFIC ANTICOAGULANTS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 11: ASIA PACIFIC ANTICOAGULANTS MARKET, BY ROUTE OF ADMINISTRATION, IN 2020
FIGURE 12: ASIA PACIFIC ANTICOAGULANTS MARKET, BY ORAL ANTICOAGULANTS, 2021-2028 (IN $ MILLION)
FIGURE 13: ASIA PACIFIC ANTICOAGULANTS MARKET, BY INJECTABLE ANTICOAGULANTS, 2021-2028 (IN $ MILLION)
FIGURE 14: ASIA PACIFIC ANTICOAGULANTS MARKET, BY DRUG CLASS, IN 2020
FIGURE 15: ASIA PACIFIC ANTICOAGULANTS MARKET, BY NOACS, 2021-2028 (IN $ MILLION)
FIGURE 16: ASIA PACIFIC ANTICOAGULANTS MARKET, BY HEPARINS & LOW-MOLECULAR-WEIGHT HEPARINS (LMWHS), 2021-2028 (IN $ MILLION)
FIGURE 17: ASIA PACIFIC ANTICOAGULANTS MARKET, BY VITAMIN K ANTAGONISTS, 2021-2028 (IN $ MILLION)
FIGURE 18: ASIA PACIFIC ANTICOAGULANTS MARKET, BY OTHER DRUG CLASS, 2021-2028 (IN $ MILLION)
FIGURE 19: ASIA PACIFIC ANTICOAGULANTS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 20: CHINA ANTICOAGULANTS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 21: JAPAN ANTICOAGULANTS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 22: AUSTRALIA & NEW ZEALAND ANTICOAGULANTS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 23: INDIA ANTICOAGULANTS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 24: SOUTH KOREA ANTICOAGULANTS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 25: THAILAND ANTICOAGULANTS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 26: INDONESIA ANTICOAGULANTS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 27: VIETNAM ANTICOAGULANTS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 28: REST OF ASIA PACIFIC ANTICOAGULANTS MARKET, 2021-2028 (IN $ MILLION)
Single User License: This License type does not allow the report to be Printed.
Enterprise License: This License type does not allow the report to be Printed.
Why http://www.marketreportsonline.com/
Published By :Inkwood Research
Price
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy